No Data
No Data
We're Not Very Worried About Third Harmonic Bio's (NASDAQ:THRD) Cash Burn Rate
Morgan Stanley Maintains Third Harmonic Bio(THRD.US) With Buy Rating, Maintains Target Price $20
Analysts Are Bullish on Top Healthcare Stocks: Third Harmonic Bio, Inc. (THRD), Collegium Pharmaceutical (COLL)
Third Harmonic Bio to Participate in Upcoming Investor Conferences in November
TD Cowen Maintains Third Harmonic Bio(THRD.US) With Buy Rating
TD Cowen Remains a Buy on Third Harmonic Bio, Inc. (THRD)